Indian Trial of Tranexamic Acid in Spontaneous Intracerebral Haemorrhage
This multicenter, pragmatic randomized, open-label clinical trial aims to assess whether Tranexamic Acid improves outcomes in adult patients with spontaneous intracerebral haemorrhage.
The participants presenting within 4.5 hours of the onset of symptoms of stroke with intracerebral haemorrhage confirmed on Computed Tomography (CT Scan) will be randomized into two groups in a 1:1 ratio using a central online randomization. The treatment arm will consist of giving intravenously 2 grams of Tranexamic Acid in 100 ml 0.9% sodium chloride administered over 45 minutes. Control arm patients will receive standard of care treatment as per the institutional protocol. In both arms, intensive systolic blood pressure reduction to less than 140 mmHg will be done using antihypertensive medications, which has to be achieved within one hour and will be maintained over next seven days. The choice of antihypertensive drug will depend on the clinician's preference.
Both groups will have a repeat CT scan after 24 hours to check for any increase in the haematoma volume. Any deterioration in the neurological status will warrant urgent brain imaging. On day 7, the patient will be assessed for their NIHSS score and mRS score. On day 90, quality of life and the functional outcome will be assessed.
TO STUDY THE EFFECT OF MATERNAL BLOOD PRESSURE CHANGES DURING SPINAL ANAESTHESIA IN PATIENTS UNDERGOING ELECTIVE CESAREAN SECTION, ON SHORT TERM NEONATAL OUTCOMES.
To evaluate the efficacy and safety of omeprazole in laryngitis due to laryngopharyngeal reflux
100 项与 Christian Medical College & Hospital 相关的临床结果
0 项与 Christian Medical College & Hospital 相关的专利(医药)
100 项与 Christian Medical College & Hospital 相关的药物交易
100 项与 Christian Medical College & Hospital 相关的转化医学